InterCure Ltd.

1.41
-0.02 (-1.40%)
At close: Mar 28, 2025, 3:58 PM
1.45
3.04%
After-hours: Mar 28, 2025, 04:36 PM EDT

Company Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally.

It offers dried cannabis inflorescences and cannabis extract mixed with oil.

The company also invests in biomed sector.

InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

InterCure Ltd.
InterCure Ltd. logo
Country IL
IPO Date Jan 28, 2019
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 270
CEO Alexander Rabinovich

Contact Details

Address:
85 Medinat ha-Yehudim Street
Herzliya,
IL
Website https://www.intercure.co

Stock Details

Ticker Symbol INCR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001857030
CUSIP Number M549GJ111
ISIN Number IL0011063760
Employer ID 00-0000000
SIC Code 2834

Key Executives

Name Position
Alexander Rabinovich Chief Executive Officer & Chairman
Amos Cohen Chief Financial Officer
Einat Zehavi Vice President of Sales
Itai Kabiljo General Counsel

Latest SEC Filings

Date Type Title
Feb 13, 2025 6-K Filing
Feb 03, 2025 6-K Filing
Jan 31, 2025 6-K/A [Amend] Filing
Jan 27, 2025 6-K Filing
Dec 30, 2024 6-K Filing
Dec 20, 2024 6-K Filing
Dec 20, 2024 6-K Filing
Nov 25, 2024 6-K Filing
Nov 04, 2024 6-K Filing
Oct 28, 2024 6-K Filing